Cambridge Investment Research Advisors, Inc. G1 Therapeutics, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$2.2 - $4.98 $220 - $498	-100 Reduced 0.59%	16,711 $38,000
Q1 2024 Apr 24, 2024	BUY	$2.1 - $4.83 $10,500 - $24,150	5,000 Added 42.33%	16,811 $73,000
Q4 2023 Feb 09, 2024	BUY	$1.12 - $3.73 $13,228 - $44,055	11,811 New	11,811 $36,000
Q1 2022 May 12, 2022	SELL	$7.6 - $11.02 $96,269 - $139,590	-12,667 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$10.16 - $16.17 $43,180 - $68,722	-4,250 Reduced 25.12%	12,667 $129,000
Q3 2021 Nov 02, 2021	BUY	$13.16 - $22.47 $50,165 - $85,655	3,812 Added 29.09%	16,917 $227,000
Q2 2021 Aug 10, 2021	BUY	$19.57 - $26.32 $93,016 - $125,098	4,753 Added 56.91%	13,105 $287,000
Q1 2021 May 07, 2021	BUY	$17.58 - $32.59 $146,828 - $272,191	8,352 New	8,352 $200,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account